Wonseok Kang - Concepedia

Author

Wonseok Kang

Samsung Medical Center ORCID

Also Known As

In Woong Han, Joong Hyun Ahn, Kang, Wonseok, W K Kang, W. K. Kang, W. Kang, W. kang, W., Kang, W.K Kang, W.K. Kang

210

Publications

3.8K

Citations

H-Index

125

Concepts

All Affiliations

Samsung Medical Center Sungkyunkwan University Yonsei University Korea Advanced Institute of Science and Technology Samsung (South Korea)

About

Wonseok Kang is an author at Samsung Medical Center specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	1.2K
2	Health Sciences	6	6	162
3	Engineering	4	4	198
4	Applied Physics	1	1	47
5	Biomedical Engineering	1	1	18

Wonseok Kang

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma? W. S. Kim, Si Yeol Song, Yong Chan Ahn, Annals of Oncology Lymphoid NeoplasiaRadiation MedicineRadiation TherapyMedicineImmunology	2001	202
Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment Jung Hee Kim, Dong Hyun Sinn, Wonseok Kang, Hepatology	2016	195
Innate-like Cytotoxic Function of Bystander-Activated CD8+ T Cells Is Associated with Liver Injury in Acute Hepatitis A Jihye Kim, Dong-Yeop Chang, Hyun Woong Lee, Immunity Acute Hepatitis AImmunologyPathologyInnate ImmunityAutoimmune Liver Disease	2018	192
Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients Y H Park, M J Park, S H Ji, British Journal of Cancer Neuro-oncologyBreast OncologySystemic Extracranial DiseaseMedicineBrain Metastasis	2009	173
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer Jia-Lin Lee, Y-K. Kang, Hye Jin Kang, British Journal of Cancer	2008	136
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial Jung Yong Hong, Hee Jin Cho, K. Jason, Genome Medicine	2022	132
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients Kyu Sik Jung, Jun Yong Park, Young Eun Chon, Journal of Gastroenterology Hepatitis DOral Antiviral TreatmentHepatologyViral HepatitisHepatitis B	2015	91
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Hepatology	2019	87
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours Hee Kyung Ahn, Joon Young Choi, K.-M. Kim, British Journal of Cancer	2013	80
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Clinical and Molecular Hepatology	2020	79

Page 1